CONTEMPLATED PRIVATE PLACEMENT – INTENDED TRANSFER OF LISTING TO OSLO BØRS

PROGO’s BIOACTIVE PEPTIDES TO SUPPORT HEALTHY IRON LEVELS TO BE LAUNCHED IN THE U.S.

HBC’S APPLICATION TO HEALTH CANADA FOR UNIQUE QUALIFIED HEALTH CLAIMS IS PROGRESSING VERY WELL AND A POSITIVE CONCLUSION IS EXPECTED DURING OCTOBER 2020

ANNOUNCES THE USE OF A VIRTUAL PLATFORM TO RECRUIT COVID-19 PATIENTS IN CANADA TO THE PHASE 2 TRIAL. WILL ALSO ASSESS THE IMPACT OF OMEGO ON HOSPITALISED PATIENTS WITH SEVERE FORMS OF COVID-19 IN MEXICO AND BRAZIL

SHARE CAPITAL INCREASE REGISTERED

New study highlights the potential of OmeGo® as a prophylactic therapy for Asthma and COPD

SECOND QUARTER & HALF YEAR 2020 FINANCIAL REPORT

ISSUANCE OF NEW SHARES FOLLOWING EXERCISE OF OPTIONS – PRIMARY INSIDER DISCLOSURE

SECURES DISTRIBUTION WITH A GLOBAL RETAILER GIANT IN THE UK, SPAIN, ICELAND, AND ONLINE FOR BRILLIANT SALMON OIL™ FOR PETS

HBC AQUIRES A 34 PERCENT STAKE IN HEALTHCARE AND PETCARE DISTRIBUTOR ATLANTIC DELIGHTS LTD FOR ACCESS TO CHINESE MARKET